CD8A and neoplasm: Despite the earlier onset of apoptosis in glycolysis-inhibited alloreactive CD8+ T cells compared to CD4+ T cells (Figure S9B), ex vivo stimulated T cells were capable of controlling tumor development and improving survival outcome compared to TCDBM + tumor and untreated donor T cell recipients (Figure 6).